Frontage Laboratories

Frontage Laboratories is a Contract Research Organization (CRO) that provides integrated, science-driven, product development services. Frontage helps biopharmaceutical organizations advance their research and development efforts with full-service offerings– including bioanalysis, preclinical and clinical studies, analytical testing, and product development support– spanning discovery stages through late-stage clinical trials. The company also provides turnkey product development, bioequivalence, and analytical services to generic and consumer health pharmaceutical companies to support abbreviated new drug applications and 505.b.2 application submissions.

John Lin

President

Abdul Mutlib

CEO

6 past transactions

Heyan Biotech

Acquisition in 2021
Heyan Biotech is a national biotech industry base, provides for target based in vitro pharmacodynamic screening and early pharmacological pharmacodynamic evaluation services in early drug discovery.

Ocean Ridge Biosciences

Acquisition in 2021
Ocean Ridge Biosciences is a life science company based in Deerfield Beach, Florida, specializing in genomic services for the health care and life science sectors. The company focuses on the extraction and analysis of RNA and proteins from diverse biological samples, utilizing a real-time PCR platform to facilitate accurate and affordable research. As demand for high-quality genomic services continues to grow for both research and clinical applications, Ocean Ridge Biosciences aims to support researchers in making informed, data-driven decisions. Its strategic location within a major metropolitan area allows for easy access to leading research universities, institutes, and hospitals, enhancing its collaborative potential within the biotechnology field.

Concord Biosciences

Acquisition in 2018
Concord Biosciences offers a comprehensive suite of non-clinical discovery support and integrated R&D services to support drug candidate development from lead identification through IND and NDA submission. Biological capabilities include early pharmacokinetic and metabolism screening, pilot toxicology evaluations, IND/NDA-enabling toxicology and DMPK development of both small molecules and biologics. Supporting the chemical development needs, Ricerca offers synthetic, medicinal and process chemistry, radiochemistry, and cGMP API manufacturing of small scale clinical batches through commercial API production, with complete analytical drug substance and drug product characterization. Ricerca’s experienced scientists deliver world-class expertise and services to help shorten time to IND and bring molecules to the clinic faster. We have the capacity and integrated scientific capabilities, on a single research site in Concord, Ohio, to deliver any size project. For the shortest and highest value based development program, from compound lead selection to regulatory filing, contact Ricerca.

BDM Consulting

Acquisition in 2015
BDM Consulting is an independent CRO specializing in biostatistics. SAS programming, and data management. BDM is composed of a group of more than 35 critical talents/experts, who excel and stand out among their peers in the industry. Its clients and partners include pharmaceutical, biotechnology, medical device companies and CROs. Striving to high quality, BDM focuses on reducing the time, cost and risk of bringing new pharmaceutical products to market.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.